Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2022;33(2):218-23
Article Links
Lebanese Hospital-Based Rheumatoid Arthritis Registry: Characteristics of Patients and Comparison with Other Populations
Houda Ziadeh1, Monique Chaaya2, Samar Rachidi3, Khalil El Asmar2, Amal Al-Hajje3, Lamiaa Hamieh4, Vicky Nahra5, Imad Uthman5
Authors Information

1Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy, Doctoral School of Science and Technology, Lebanese University, Beirut, Lebanon

2Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon

3Clinical and Epidemiological Research Laboratory, Faculty of Pharmacy-Clinical Pharmacy Department, Lebanese University, Beirut, Lebanon

4Department of Dermatology, American University of Beirut, Beirut, Lebanon

5Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon

Keywords: rheumatoid Arthritis, AUBMC, Lebanon, RA Registry, biologic agents
References
  1. Turesson C. Swiss Med Wkly 2016 Apr 5;146:w14290.
  2. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008 Jan;58(1):15-25.
  3. Englund M, Jöud A, Geborek P, Felson DT, Jacobsson LT, Petersson IF. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology (Oxford) 2010 Aug;49(8):1563-9.
  4. Humphreys JH, Verstappen SM, Hyrich KL, Chipping JR, Marshall T, Symmons DP. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register. Ann Rheum Dis 2013 Aug;72(8):1315-20.
  5. Chaaya M, Slim ZN, Habib RR, Arayssi T, Dana R, Hamdan O, et al. High burden of rheumatic diseases in Lebanon: a COPCORD study. Int J Rheum Dis 2012 Apr;15(2):136-43.
  6. Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis. Rheumatology (Oxford) 2012 Dec;51 Suppl 6:vi28-36.
  7. Nikiphorou E, Buch MH, Hyrich KL. Biologics registers in RA: methodological aspects, current role and future applications. Nat Rev Rheumatol 2017;13(8):503-10.
  8. Mariette X, Gottenberg JE, Ravaud P, Combe B. Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries. Rheumatology (Oxford) 2011;50(1):222-9.
  9. Curtis JR, Jain A, Askling J, Bridges SL Jr, Carmona L, Dixon W, et al. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum 2010 Aug;40(1):2-14.e1.
  10. Watson K, Symmons D, Griffiths I, Silman A. British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv42-3.
  11. Kievit W, Fransen J, Oerlemans AJ, Kuper HH, van der Laar MA, de Rooij DJ, et al. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Ann Rheum Dis 2007;66(11):1473-8.
  12. Strangfeld A, Albrecht K. Sicherheit von Biologika bei rheumatoider Arthritis: Ergebnisse aus dem deutschen RABBIT-Register. Aktuelle Rheumatologie 2018;43(05):383-9.
  13. Virkki L, Aaltonen K, Nordstrom D. [Biological therapy in rheumatoid arthritis based on ten years of registry surveillance in Finland]. Duodecim 2010;126(12):1487-95.
  14. Kvien TK, Heiberg, Lie E, Kaufmann C, Mikkelsen K, Nordvåg BY, et al. A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 2005;23(5 Suppl 39):S188-94.
  15. Carmona L, Descalzo MA, Ruiz-Montesinos D, Manero-Ruiz FJ, Perez-Pampin E, Gomez-Reino JJ; et al. Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0. Rheumatology (Oxford) 2011;50(1):85-92.
  16. Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, et al. Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 2006;65(6):707-12.
  17. Al-Saleh J, Narainen M Al Marzooqi A. Does Delay Matter in Early Rheumatoid Arthritis? Hamdan Medical Journal 2020;13(1):27-31.
  18. Al-Herz A, Al-Awadhi A, Saleh K, Al-Kandari W, Hasan E, Ghanem A, et al. A Comparison of Rheumatoid Arthritis Patients in Kuwait with Other Populations: Results from the KRRD Registry. Br J Med Med Res 2016;14:1-11.
  19. Namas R, Joshi A, Ali Z, Al Saleh J, Abuzakouk M. Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates. Int J Rheumatol 2019;2019:3057578.
  20. Dargham SR, Zahirovic S, Hammoudeh M, Al Emadi S, Masri BK, Halabi H, et al. Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients. PLoS One 2018;13(12):e0208240.
  21. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014;73(1):62-8.
  22. Attar SM. Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity. Saudi Med J 2015;36(6):685-91.
  23. Salti N, Chaaban J, Naamani N. The Economics of Tobacco in Lebanon: An Estimation of the Social Costs of Tobacco Consumption. Subst Use Misuse 2014;49(6):735-42.
  24. Alam F, Hammoudeh M Emadi SA. FRI0758-HPR Co-morbidity profile in patients with rheumatoid arthritis. data from rheumatoid arthritis registry in qatar. Ann Rheum Dis 2017 76(Suppl 2):1504-05.
  25. Al-Rubeaan K. The impact of diabetes mellitus on health and economy of Gulf Cooperation Council countries. Diabetes Manag 2014;4:381-90.
  26. Tailakh A, Evangelista LS, Mentes JC, Pike NA, Phillips LR, Morisky DE. Hypertension prevalence, awareness, and control in Arab countries: a systematic review. Nurs Health Sci, 2014. 16(1):126-30.
  27. Khadadah M. The cost of asthma in Kuwait. Med Princ Pract 2013;22(1):87-91.
  28. Irani C, Adib S, Halaby G, Sibai A. Obesity/overweight and asthma control in LEBANESE adults: a cross-sectional study. BMC Public Health 2019;19(1):769.
  29. Mian A, Ibrahim F, Scott DL. A systematic review of guidelines for managing rheumatoid arthritis. BMC Rheumatol 2019 Oct 22;3:42.
  30. Alawneh KM, Khassawneh BY, Ayesh MH, Smadi M. Rheumatoid arthritis in Jordan: A cross sectional study of disease severity and associated comorbidities. Ther Clin Risk Manag 2014 May 19;10:363-6.